| 09/17/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/25/2026 5:06 AM | Sanofi (1121404) Filer | Form N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company | |
| 08/12/2026 7:09 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/12/2026 7:18 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 2:45 PM | Attovia Therapeutics, Inc. (2058707) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2026 6:34 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2026 5:28 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/22/2026 8:50 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 07/17/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/07/2026 8:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for SNYNF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/30/2026 12:27 PM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/30/2026 11:54 AM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/30/2026 10:45 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/30/2026 10:49 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/24/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/22/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/12/2026 10:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/08/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2026 5:06 AM | Sanofi (1121404) Filer | Form SD Specialized Disclosure Report | |
| 05/27/2026 9:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/06/2026 5:00 AM | Agomab Therapeutics NV (2020932) Subject Sanofi (1121404) Filed by | Form SCHEDULE 13G | |
| 05/05/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2026 5:04 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 11:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 5:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/10/2026 8:58 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 03/31/2026 11:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 10:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 9:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 5:15 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/23/2026 8:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:28 PM | Sanofi (1121404) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 11:34 AM | Sanofi (1121404) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/17/2026 11:44 AM | Sanofi (1121404) Filer | Form IRANNOTICE | |
| 02/17/2026 8:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 8:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/11/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better.
This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today |
| 02/10/2026 8:18 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/10/2026 5:06 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 02/06/2026 9:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 5:17 AM | Sanofi (1121404) Filer | Form S-8 POS | |
| 01/30/2026 6:55 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/29/2026 7:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 5:37 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/23/2026 8:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 5:11 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 01/09/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:42 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:44 PM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 12/29/2025 5:22 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:23 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 8:52 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 11:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 9:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 10:30 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:29 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/14/2025 4:34 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 11/04/2025 9:51 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/03/2025 10:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 12:48 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/29/2025 10:15 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/28/2025 9:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/27/2025 8:12 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:13 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:15 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:17 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:20 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 7:32 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/27/2025 6:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2025 11:07 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/26/2025 8:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/22/2025 1:59 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2025 11:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |